Conferences  >  Medicine & Healthcare  >  Pharmacology and Drug Development  >  Any Location (virtual event)

Oxford Global

"Join global innovators at our symposium focused on advanced drug target screening. Explore fragment, CRISPR, phenotypic, target-based, virtual, and structure-based screening methods. Engage with leaders to discuss best practices and advancements. Discover cutting-edge techniques in fragment and CRISPR screening for identifying novel drug targets, ensuring you stay at the forefront of drug discovery. Participate in discussions on enhanced cell screening platforms and virtual & structure-based approaches. The event concludes with the ‘Harnessing Advanced Screening Approaches for Drug Target Identification & Validation’ report, summarising key insights and methodologies for effective drug discovery utilisation."

Digital Marketing Executive;     Email: c.donohoe@oxfordglobal.com

Drug delivery, target identification, computational biology, medicinal chemistry

Biotechnology,    Genomics and Bioinformatics

The European Association for Cancer Research and Boehringer Ingelheim

We return to this topic for its second edition to focus on the basic and clinical aspects of the regulation of the Mitogen Activated Protein Kinase (MAPK) pathway, one of the most commonly mutated signalling pathways in human cancers. The programme will include new insights about the mechanisms of action of the new generation of pan-RAS inhibitors and rational combination therapies.

Email: christopher.iliffe@eacr.org

cancer research, oncology, MAPK pathway, small molecule inhibitors, intrinsic resistance, adaptive resistance, effective cancer therapy agents, pan-RAS inhibitors, gene regulation, target validation, drug development, clinical and translational opportunities, rational combination therapies, cross-resistance to immune modulators

Oncology,    Molecular Biology